Innate Immune Modulation
Innate Immune Modulation is a pharmacological intervention that selectively alters the functional activity of the innate immune system to enhance, suppress, or redirect its responses to pathogens or pathological states.
5.2K
Publications
319.6K
Citations
31.8K
Authors
4.4K
Institutions
Publications per year
2017–2026
1.8K
Parents
5.2K
IL-10 inhibits cytokine production by activated macrophages
David Fiorentino, Albert Zlotnik, Tim R. Mosmann et al. · The Journal of Immunology · 1991 · 2.9K citations · Full text
Statins as a newly recognized type of immunomodulator
Brenda R. Kwak, Flore Mulhaupt, Samir Myit et al. · Nature Medicine · 2000 · 1.4K citations
1–5 of 5.2K
31.8K
21
h-index
20
h-index
16
h-index
15
h-index
15
h-index
1–5 of 31.8K
4.4K
National Institutes of Health
Bethesda, United States
46 h-index
239 publications
32.9K citations
Harvard University
Cambridge, United States
45 h-index
333 publications
35.9K citations
Inserm
Paris, France
43 h-index
440 publications
42.7K citations

Chinese Academy of Sciences
Beijing, China
41 h-index
402 publications
33.8K citations

Centre National de la Recherche Scientifique
Paris, France
38 h-index
302 publications
18.9K citations
University of Michigan
Ann Arbor, United States
34 h-index
205 publications
12.5K citations

Radboud University Nijmegen
Nijmegen, The Netherlands
32 h-index
289 publications
35.2K citations
Jilin University
Changchun, China
32 h-index
340 publications
21.4K citations
1–8 of 4.4K
JI · 368 publications · 40.9K citations
107
h-index
JBC · 87 publications · 7.2K citations
50
h-index
PNAS · 61 publications · 8.5K citations
48
h-index
146 publications · 8.7K citations
47
h-index
148 publications · 6.3K citations
46
h-index
1–5